Report questions high published royalty rates for voice codec SEPs
Analysis from Stout suggests rates sought by certain Enhanced Voice Services (EVS) patent owners are out of line with the overall 3G/4G/5G FRAND landscape
Analysis from Stout suggests rates sought by certain Enhanced Voice Services (EVS) patent owners are out of line with the overall 3G/4G/5G FRAND landscape
Terran Biosciences has emerged from obscurity to snap up slew of IP rights in the past two months
The latest wireless standard hasn’t yet found its ‘killer app’ for consumers, and it’s affecting licensing negotiations
A composite index of publicly-quoted entities with largest US portfolios has enjoyed strong performance since 2018
15 February 2021
A major milestone in the medical cannabinoid patent market has been passed
09 February 2021
A deep dive into the trail-blazing biopharma business established by former hedge fund partner Vivek Ramaswamy
02 February 2021
O-Film, a smartphone supplier that has counted Apple among its clients, spins 900+ assets to a related party as its business comes under pressure
26 January 2021
Hesai Photonics Technology reveals monetary details of settlement, which also involves ongoing royalty payments through 2030
22 January 2021
Despite a turbulent 2020 for pharma transactions, it is possible to discern a few patterns for activity in the market this year
19 January 2021
USPTO report on non-market patent incentives shows how Chinese applicants are being encouraged to obtain more foreign rights
14 January 2021
Patent licensing is as much an art as it is a science, explain some of those featured in the new IAM Strategy 300 Global Leaders guide
22 December 2020
As non-patent assets become increasingly important, pharma and biotech innovators must adapt their IP strategies.
22 December 2020
It has been a year of creative and flexible deal-making with many life sciences entities taking advantage of the revenues this kind of IP monetisation can deliver
16 December 2020
Get unlimited access to all IAM content